PPT-Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

An Interactive Oncology Grand Rounds Series Joyce OShaughnessy MD Chair Breast Cancer Research Program Baylor Charles A Sammons Cancer Center Celebrating Women Chair in Breast Cancer Research. Elaine R. Mardis, Ph.D.. Professor of Genetics. Co-director, The Genome Institute. NCI Workshop: NGS in Clinical Decision Making. Why is cancer WGS analysis “easy”?. The comparison of a patient’s tumor to their normal genome . Jennifer M. Matro, MD. Rena Rowan Breast Center. Abramson Cancer Center. University of Pennsylvania. Overview. What is metastatic breast . c. ancer (MBC)?. Who is at risk?. Subtypes of Breast Cancer. . Dr.Mina. . Tajvidi. Radiation . oncologist. . Fewer than 10 percent of women present with metastatic disease at the time of diagnosis. the majority of women who relapse after definitive therapy for early stage or locally advanced disease will do so with disseminated metastatic disease rather than an isolated local recurrence. Targeting endocrine-resistance pathways in breast cancer Clara Natoli, Chieti Endocrine responsive breast cancer Luminal A High expression of ER & ER-related genes Lower Dr.Mina. . Tajvidi. . Radiation . oncologist. . Endocrine therapy in breast cancer. Endocrine therapy for hormone receptor positive early stage breast cancer in premenopausal women. Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. Antonella Brunello . Kwok-Leung Cheung. Disclosure. No . conflict. of . interests. Learning objectives. To . discuss the pros and cons of adjuvant chemotherapy for breast cancer in the elderly. To . VeruInc Oncology Biopharmaceutical Company Focused on Prostate Cancer and Breast CancerVeru Corporate PresentationJefferies Virtual Healthcare ConferenceJune 1 June 4 2021Forward looking statements2Th Breast Cancer : How important is it? . It is the most common cancer among women in lower-and-middle-income in Asian countries. . Its cost to society in terms of . - use of healthcare resources . HOPC. Mrs GV is a 78 year old women who presented to Cabrini ED with acute dyspnoea is the setting of recent malignant pleural effusion in the setting of Metastatic Breast Ca.. Nov 2010: Self Detected left breast lump (AJCC Stage . Background of lower back pain for 3/12 . No past medical Hx.. Social Hx: . Married 2 small children, works in hospital admin. Regular Menstrual periods. Family Hx: . Aunt: Breast Ca 55. Aims. O/E:. Palpable LN under the right axilla. Key recommendations. 1. National and local workforce planning is essential. Health Education England and all Cancer Alliances should urgently ensure there are enough healthcare professionals to deliver high-quality and timely diagnosis, treatment and care to local women.. Elana Plotkin, CMP-HC. 1. , Marianne Gandee, MA. 2. , Lorna Lucas , MSM. 1. 1 Association of Community Cancer Centers, Provider Education, Rockville, MD, USA 2 Association of Community Cancer Centers, Development, Rockville, MD, USA. Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhutan. Define the breast cancer. Is the cancer operable?. Stage 1: systemic therapy after surgery (and radiation if breast conservation). Stage 2: systemic therapy before or after therapy.